You are here
Litron Laboratories Ltd
UEI: LJH7LE9AUHL5
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Rapid Screen for Genotoxicants, Chemoprotectors, and Radioprotectors
Amount: $577,635.00DESCRIPTION (provided by applicant): This research project addresses an important problem faced by the chemical and drug industries-their requirement to evaluate the DNA damaging potential of ever inc ...
SBIRPhase II2007Department of Health and Human Services National Institutes of Health -
Rapid Screen for Genotoxicants, Chemoprotectors, and Radioprotectors
Amount: $133,336.00DESCRIPTION (provided by applicant): This research project addresses an important problem faced by the chemical and drug industries? their requirement to evaluate the DNA damaging potential of ever la ...
SBIRPhase I2006Department of Health and Human Services National Institutes of Health -
In vivo mutation assay based on pig-a locus
Amount: $92,480.00DESCRIPTION (provided by applicant): Mutation to DNA is a primary mechanism by which cancers arise. These events have also been implicated in diseases such as atherosclerosis, and processes such ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
Automation of the vitro Micronucleus Assay
Amount: $423,418.00DESCRIPTION (provided by applicant): The induction of DNA damage and the resulting sequelae of mutations and chromosomal rearrangements are primary mechanisms by which cancers arise. DNA damage has ...
SBIRPhase II2003Department of Health and Human Services National Institutes of Health -
Assessing toxicity with an ex vivo erythropoiesis system
Amount: $100,000.00DESCRIPTION (provided by applicant): Humans are exposed to toxic chemical and physical agents through a variety of sources. Of extreme concern are agents which can damage DNA, as genotoxicity is assoc ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health -
MEASURING CYTOGENETIC DAMAGE IN HUMAN BLOOD
Amount: $0.00Humans are exposed to genotoxic agents through a variety of sources. Micronucleus (MN) formation is an endpoint which can be used to detect DNA damage resulting from clastogenic or aneugenic mechanism ...
SBIRPhase I2002Department of Health and Human Services National Institutes of Health -
MEASURING CYTOGENETIC DAMAGE IN HUMAN BLOOD
Amount: $483,062.00Humans are exposed to genotoxic agents through a variety of sources. Micronucleus (MN) formation is an endpoint which can be used to detect DNA damage resulting from clastogenic or aneugenic mechanism ...
SBIRPhase II2002Department of Health and Human Services National Institutes of Health -
AUTOMATION OF THE IN VITRO MICRONUCLEUS ASSAY
Amount: $98,597.00The in vitro nucleus test is increasingly being used as an alternative to the more costly and time consuming in vitro chromosome aberration assay as a screen for detecting a chemical's genotoxic poten ...
SBIRPhase I2002Department of Health and Human Services National Institutes of Health -
Flow Cytometric Method to Analyze Micronuclei
Amount: $0.00N/A
SBIRPhase I2001Department of Health and Human Services National Institutes of Health -
Flow Cytometric Method to Analyze Micronuclei
Amount: $265,514.00N/A
SBIRPhase II2001Department of Health and Human Services National Institutes of Health